VEGFC and neoplasm: Several studies have confirmed that the net benefit of VEGFC release from melanoma cells and tumor-associated macrophages (TAM) to induce lymphangiogenesis is to promote LN metastasis of melanoma [90,91,92,93], which is considered a marker of a poor prognosis of melanoma [94,95,96,97].